Taking on new challenges in Market Access with David McConkey, Gilead Sciences

Om avsnittet

Welcome back to the Market Access Matters podcast! In the first episode of series 2, Louise interviews David McConkey, Virology and Oncology Global Value and Access Director at Gilead Services.
Having started his career in consulting and then working across global and country roles, David has a breadth of experience in market access.
In this discussion he shares his experiences of taking on new challenges, leading teams into new territories and what he's learnt along the way.

The opinions shared in this episode are David's own views and not those of the company he is working for.

Send us Fan Mail

Om avsnittet

Fler avsnitt

Understanding Payer Perceptions with Megan O'Brien

Pricing Under Pressure: What MFN Really Means for Global Strategy

Navigating Global Policy Shifts with Nikhil Taxak

Beyond the Headlines: Understanding MFN's True Impact on Market Access

Revolutionary Strategies in Orphan Drug Development with Isabel Rubio

Elevating launch excellence: The strategic value of early market access involvement with Lizzie Shanahan, Sanofi

Getting ready for the JCA: Why cross-functional collaboration matters with Silvy Mardiguian, BeiGene

The rise of multi-stakeholder capitalism in market access with Jie Shen, CSL

Authentic leadership in Market Access with Katrin Jack, Galderma

Market Access in emerging markets with Ezgi Erdogan, GSK